← Back to all trials
Active Not Recruiting
NCT00560651
German Corneal Cross Linking Register
Conditions: Keratoconus
Sex: All
Healthy volunteers: No
Enrollment: 356
Sponsor: Suphi Taneri
Location: University of Saar Homburg
Summary
Corneal Cross Linking is new treatment modality for patients with keratoconus. A keratoconus is characterized by progressive bulging and thinning of the eye's cornea. Keratoconus is a potentially severely sight impairing condition that may necessitate corneal transplantation in the progressive state.
Corneal Cross Linking is designed to
* increase the cornea's mechanical stability
* to stop progression of bulging and thinning of the cornea
* to prevent the need for corneal transplantation
Corneal Cross Linking is performed by
1. Applying Riboflavin (Vitamin B2) eye drops every 2 minutes for 30 minutes to the cornea
2. Illuminating the cornea with UV-light
This register of Corneal Cross Linking procedures performed in Germany serves to
* gather long-term results
* detect rare complications and side-effects
* evaluate the efficacy in a large number of patients
Eligibility Criteria
Inclusion Criteria:
* Patients diagnosed with keratokonus and treated with corneal cross Linking in Germany
Exclusion Criteria:
* Non-ectatic conditions
Source: ClinicalTrials.gov (NCT00560651). StuddyBuddy aggregates publicly available trial information.